Abstract
Patients with low-density lipoprotein cholesterol (LDL-C) ≥190 mg/dL are at high risk of atherosclerotic cardiovascular disease events. Treatment guidelines recommend intensive treatment in these patients. Variation in the use of lipid-lowering therapies (LLTs) in these patients in a national sample of cardiology practices is not known. Using data from the American College of Cardiology National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence registry, we assessed the proportion of patients with LDL-C ≥190 mg/dL (n=49 447) receiving statin, high-intensity statin, LLT associated with ≥50% LDL-C lowering, ezetimibe, or a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor between January 2013 and December 2016. We assessed practice-level rates and variation in LLT use using median rate ratio (MRR) adjusted for patient and practice characteristics. MRRs represent the likelihood that 2 random practices would differ in treatment of identical patients with LDL-C ≥190 mg/dL. The proportion of patients receiving a statin, high-intensity statin, LLT associated with ≥50% LDL-C reduction, ezetimibe, or PCSK9 inhibitor were 58.5%, 31.9%, 34.6%, 8.5%, and 1.5%, respectively. Median practice-level rates a...Continue Reading
References
Aug 14, 1998·BMJ : British Medical Journal·L A BeroM A Thomson
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Dec 13, 2005·Health Services Research·Patrick J O'Connor
Feb 3, 2006·Cardiovascular Drugs and Therapy·Eric BruckertBernard Bégaud
Oct 9, 2008·European Heart Journal·Andrew NeilSteve E Humphries
Nov 13, 2008·BMJ : British Medical Journal·Jorie VersmissenEric J G Sijbrands
Sep 30, 2009·Archives of Internal Medicine·Hardeep SinghLaura A Petersen
Jul 14, 2010·Journal of the American College of Cardiology·Paul S ChanJohn A Spertus
Apr 14, 2011·BMC Medical Informatics and Decision Making·Sylvia J HysongHardeep Singh
Oct 11, 2011·American Heart Journal·Salim S ViraniLaura A Petersen
Nov 25, 2011·The American Journal of Cardiology·Masa-Aki KawashiriMasakazu Yamagishi
Sep 25, 2012·Journal of the American College of Cardiology·John C MessengerUNKNOWN NCDR Science and Quality Oversight Committee Data Quality Workgroup
Sep 11, 2013·American Heart Journal·Warner M MampuyaLeslie Cho
Nov 14, 2013·Journal of the American Pharmacists Association : JAPhA
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
May 13, 2014·Journal of the American College of Cardiology·Ravi S HiraSalim S Virani
Jan 17, 2015·Journal of the American College of Cardiology·Ravi S HiraSalim S Virani
Nov 10, 2015·The American Journal of Medicine·Sripal BangaloreDavid D Waters
Jan 17, 2016·Atherosclerosis·Yashashwi PokharelSalim S Virani
Mar 19, 2016·Journal of the American College of Cardiology·Leopoldo Perez de IslaUNKNOWN SAFEHEART Investigators
Mar 26, 2016·Circulation. Cardiovascular Genetics·Emil M deGomaJoshua W Knowles
Apr 7, 2016·Journal of the American College of Cardiology·Amit V KheraSekar Kathiresan
Apr 10, 2016·Clinical Cardiology·Yashashwi PokharelSalim S Virani
May 22, 2016·Journal of Clinical Lipidology·Salim S ViraniChristie M Ballantyne
Jul 1, 2016·Circulation·Amanda M PerakDonald M Lloyd-Jones
Sep 14, 2016·Cardiovascular Drugs and Therapy·Henry N GinsbergErik Stroes
Sep 17, 2016·Journal of the American College of Cardiology·Yashashwi PokharelSalim S Virani
Dec 23, 2016·Science·Noura S Abul-HusnMichael F Murray
May 24, 2017·Journal of Clinical Lipidology·Carl E OrringerJames A Underberg
Jul 25, 2017·Annals of Internal Medicine·Huabing ZhangAlexander Turchin
Aug 29, 2017·The New England Journal of Medicine·Paul M RidkerUNKNOWN CANTOS Trial Group
Sep 8, 2017·Circulation·Antonio J Vallejo-VazKausik K Ray
Citations
Mar 30, 2019·Journal of the American Heart Association·Ulrich LaufsErik S G Stroes
Dec 5, 2019·Clinical Drug Investigation·Carlo PiccinniRosa Gini
Oct 6, 2018·Current Medical Research and Opinion·Ming-Hui TaiGavin Worth
Apr 9, 2020·European Heart Journal·Christie M Ballantyne, Salim S Virani
Nov 12, 2020·Cardiovascular Diabetology·Mario Luca MorieriUNKNOWN the DARWIN-T2D Network of the Italian Diabetes Society
Jan 11, 2020·Journal of the American College of Cardiology·Thomas M MaddoxFrederick A Masoudi
Jan 28, 2021·Circulation·Salim S ViraniUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Nov 20, 2020·Curēus·Chetana SinghDomonick K Gordon
Jun 16, 2019·American Heart Journal·Michael G NannaEric D Peterson
Nov 15, 2019·American Heart Journal·Christopher P CannonUNKNOWN GOULD Investigators
Apr 28, 2021·Journal of the American Heart Association·Elias J DayoubPeter W Groeneveld
Jul 31, 2021·American Journal of Preventive Cardiology·Matthew E GoldAnn Marie Navar
Aug 19, 2021·Circulation. Cardiovascular Quality and Outcomes·Daniel M BlumenthalJason H Wasfy
Sep 2, 2021·Journal of the American Heart Association·Wael E EidJoseph R Nolan
Sep 26, 2021·Current Opinion in Lipidology·Toshiyuki Nishikido, Kausik K Ray